@phdthesis{Schweeberg2019,
  author    = {Schweeberg, Sarah},
  title     = {Biomedizinische Anwendung von Nanodiamant: Untersuchungen zu den Wechselwirkungen mit der biologischen Umgebung und zur gezielten Wirkstofffreisetzung},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-174619},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Nanodiamant bietet in der Medizin und in der Biologie zahlreiche Anwendungsm{\"o}glichkeiten aufgrund der guten Biokompatibilit{\"a}t und geringen Toxizit{\"a}t. Durch die umfangreichen Funktionalisierungsm{\"o}glichkeiten der Oberfl{\"a}che der nanometergroßen Partikel k{\"o}nnen viele unterschiedliche Wirkstoffe, Rezeptormolek{\"u}le oder Peptidsequenzen angebunden werden ,die zusammen mit Nanodiamant ein anderes, durchaus besseres Wirkprofil aufweisen als der Wirkstoff allein. Ziel dieser Arbeit war die Synthese eines pH-labilen Linkersystems, dass hydroxylhaltige Wirkstoffe kovalent bindet und zusammen mit Nanodiamant in die Zelle, in der ein saurer pH-Wert herrscht, eingeschleust werden. {\"U}ber die {\"A}nderung des pH-Wertes in der Zelle soll der Wirkstoff freigesetzt werden und seine Wirkung entfalten k{\"o}nnen. Weiterhin wurde ein pH-labiles Linkersystem auf der Basis eines Hydrazons hergestellt. {\"U}ber das synthetisierte Hydrazinderivat k{\"o}nnen Wirkstoffe, die {\"u}ber eine Aldehyd- oder Ketonfunktion verf{\"u}gen angebunden werden und pH-labil in der Zelle freigesetzt werden. Zus{\"a}tzlich tr{\"a}gt der Nanodiamant ein kovalent angebundenes Targeting-Molek{\"u}l, welches eine verbesserte Adressierung der Wirkorte gew{\"a}hr¬leisten soll. Die Freisetzung wurde mittels UV-Vis-Spektroskopie detektiert und ausgewertet. Neben der spezifischen Funktionalisierung von Nanodiamant besitzt auch die Interaktion der Nanodiamantpartikel mit biologischen Medien eine besondere Bedeutung f{\"u}r zuk{\"u}nftige biomedizinische Anwendungen. Wenn die Partikeloberfl{\"a}che durch Proteinadsorption gegen{\"u}ber dem Wirkort abgeschirmt wird, so kann der angebundene Wirkstoff gegebenenfalls nicht freigesetzt werden und somit nicht seine Wirkung entfalten und bleibt letztlich ungenutzt. So war es von besonderem Interesse die Wechselwirkungen von Nanodiamant in Humanserum und auch weiteren physiologischen Medien zu untersuchen. Dabei wurden sowohl freie Nanodiamantpartikel als auch solche, die auf klinisch bereits eingesetzten Ger{\"u}stmaterialien im Bereich der Therapie großer Knochendefekte adsorbiert waren, untersucht. Auch wurden die Wechselwirkungen von Nanodiamant mit der physiologischen Umgebung untersucht, die zur Agglomeration der Nanopartikel f{\"u}hren k{\"o}nnen. Es wurde ein unter¬schiedliches Agglomerationsverhalten der Nanodiamanten in w{\"a}ssriger Umgebung verglichen mit Nanodiamanten in physiologischen Medien sowie deren Stabilit{\"a}t im Serum beobachtet. Durch die in dieser Arbeit vorgestellten Untersuchungen konnten wichtige Erkenntnisse zur Wechselwirkung verschieden pr{\"a}parierter und funktionalisierter Nanodiamanten mit physiologisch relevanten Umgebungen sowie zu stimuli-responsiven Wirkstofffreisetzung aus Nanodiamant-Konjugaten gewonnen werden. Zudem wurde mit der Untersuchung der angelagerten Proteine um Nanodiamant ein erster Schritt in Richtung eines umfassenden Verst{\"a}ndnisses der Wechselwirkung dieses Materials mit biologischen Umgebungen unternommen. Auch wenn diese Wechselwirkungen sehr komplex sind, so sind erste Aussagen bez{\"u}glich der Art der angelagerten Proteine m{\"o}glich. Erste Versuche der Stabilisierung von Nanodiamant in physiologischen Medien wurden ebenfalls erfolgreich durchgef{\"u}hrt und zeigen eine effiziente und einfache M{\"o}glichkeit, Nanodiamant in biologischen Medien vor der Agglomeration zu bewahren. Die im Rahmen dieser Arbeit gewonnen Erkenntnisse bez{\"u}glich mehrfacher Funktionalisierungsm{\"o}glichkeiten von Nanodiamant sowie dessen Stabilisierung in physiologischen Medien zeigen die breite Anwendungsm{\"o}glichkeit und das enorme Potential von Nanodiamant im Bereich medizinischer und biologischer Anwendungen auf.},
  subject      = {Nanopartikel},
  language  = {de}
}
@phdthesis{Hinderer2021,
  author    = {Hinderer, Sandra},
  title     = {Charakterisierung der Freisetzung verschiedener Antibiotika aus resorbierbaren anorganischen Knochenersatzmaterialien sowie die Untersuchung des Einflusses auf materialcharakteristische Eigenschaften},
  doi       = {10.25972/OPUS-23083},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-230836},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2021},
  abstract  = {Synthetische anorganische Knochenersatzmaterialien auf Calcium-Phosphat- und Magnesium-Phosphat-Basis wurden in der hier vorliegenden Dissertation mit verschiedenen handels{\"u}blichen Antibiotika versetzt und deren Freisetzungsverhalten charakterisiert. Zudem wurde der Einfluss des Antibiotikazusatzes auf bestimmte materialcharakteristische Eigenschaften untersucht, hierbei fanden die Quecksilberporosimetrie, die R{\"o}ntgendiffraktometrie und die Rasterelektronenmikroskopie ihre Anwendung. Insbesondere f{\"u}r die Knochenersatzmaterialien auf Calcium-Phosphat-Basis sollte eine klinisch praktikable und demnach m{\"o}glichst einfache Methode etabliert werden, um die Kombination mit einem Antibiotikum durchzuf{\"u}hren. Die Detektion der Antibiotika erfolgte mit Hilfe eines UV/VIS-Spektrophotometers. Zudem wurde f{\"u}r einige ausgew{\"a}hlte Kombinationen aus Antibiotikum und Knochenersatzmaterial durch einen Agardiffusionstest die antibakterielle Wirkung nach der Freisetzung aus dem jeweiligen Tr{\"a}germaterial best{\"a}tigt.},
  subject      = {Wirkstofffreisetzung},
  language  = {de}
}
@phdthesis{KraehenbuehlAmstalden2018,
  author    = {Kr{\"a}henb{\"u}hl Amstalden, Maria Cecilia},
  title     = {Development of a bacterial responsive antibiotic release system},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-163386},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2018},
  abstract  = {A major problem regarding public health is the emergence of antibiotic resistant bacterial strains, especially methicillin resistant Staphylococcus aureus (MRSA). This is mainly attributed to the unnecessary overuse of antimicrobial drugs by patients; however, one aspect that is often neglected is their untargeted mechanism of action, affecting not only the infection itself but also commensal bacteria which are often opportunistic pathogens causing many diseases as well. Therefore, our goal was to develop a bioresponsive antibiotic delivery system triggered by virulence factors. The designed system is comprised of a polymer to enhance its pharmacokinetic profile, a peptide cleavable linker, and the antibiotic agent itself. The bacterial protease aureolysin which is expressed by S. aureus during infections would cleave the linker and partially release the antibiotic which would be still attached to a remaining tetrapeptide. These would be cleaved by a group of proteases naturally present in plasma called aminopeptidases, finally releasing the compound. In the first part of this project, we searched for a suitable sequence to serve as a cleavable linker. It should be sensitive towards the target bacterial protease but not be cleaved by any human enzymes to guarantee the specificity of the system. Therefore, we synthesized three peptide sequences via Solid Phase Peptide Synthesis and incubated them with aureolysin as well as with many human matrix Metalloproteases. The analysis and quantification of enzymatic activity was monitored chromatographically (RP-HPLC). The plasminogen originated sequence was chosen since it was not sensitive towards MMPs, but cleaved by aureolysin. In the second part, we tried to incorporate the chosen peptide sequences as crosslinkers in hydrogel formulations. The purpose was to physically incorporate the antibiotic within the hydrogel, which would be released by the cleavage of those sequences and the consequent loosening the hydrogel net. For that purpose we used a commercially available hydrogel kit with a PVA matrix modified with maleimide, which allows a conjugation reaction with thiol functionalized crosslinkers. Three fluorophores were chosen to serve as antibiotic models and a diffusion assay was performed. Only the glomerular structured Green Fluorescent Protein (GFP) presented a low diffusion rate, thus the aureolysin release assays were performed only using this prototype. Assays showed that with a low hydrogel polymer concentration, the fluorophore either quickly diffused into the medium or was not released at all. The physical incorporation of the antibiotic within the hydrogel pores was therefore abolished as a suitable release approach. For a second attempt, we covalently bound a fluorophore to the linker, which was conjugated to the hydrogel matrix. The incubation with aureolysin and subsequent RP-HPLC analysis showed a peak with the same retention time correspondent to the fragment product after cleavage of the free linker. This is a proof that the concept of linking the peptide sequence to the antibiotic is a promising strategy for its bioresponsive release. Within the third part of this study, we analyzed the degradation of the resulted fragment after aureolysin activity and subsequent full release of the antibiotic by human aminopeptidases. We determined the concentration of those enzymes in human plasma and synthesized the fragment by conjugating the tetrapeptide sequence to aminofluorescein via EDC/NHS reaction. By incubating the construct with the lowest aminopeptidase concentration measured in plasma, the fluorophore was completely released within two hours, showing the efficacy of these enzymes as bioresponsive agents. The last part was the construction of the PEGylated linker-antibiotic. For this purpose we chose the tetracycline like antibiotic chelocardin (CHD) as our prototype. The conjugation of the linker- CHD to the polymer was performed by copper free click chemistry. The cleavage rate of the linker by aureolysin was very similar to the one obtained for the free peptide, indicating that the PEGylation does not interfere on the enzymatic activity. However, by trying to increase the loading ratio of chelocardin onto the polymer, we observed a very low cleavage rate for the system, indicating the formation of aggregates by those constructs. The designed system has proved to be a smart strategy for the delivery on demand of antibiotics in which the drug is only released by the presence of S. aureus during their virulent state.},
  subject      = {Arzneimittelforschung},
  language  = {en}
}
@phdthesis{Heffels2012,
  author    = {Heffels, Karl-Heinz},
  title     = {Functional nanofibres for regenerative medicine},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-75684},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2012},
  abstract  = {This thesis concerned the design and examination of a scaffold for tissue engineering applications. The template for the presented scaffold came from nature itself: the intercellular space in tissues that provides structure and support to the cells of the respective tissue, known as extracellular matrix (ECM). Fibres are a predominant characteristic feature of ECM, providing adhesion sites for cell-matrix interactions. In this dissertation a fibrous mesh was generated using the electrospinning technique to mimic the fibrous structure of the ECM. Two base polymers were explored: a biodegradable polyester, poly(D,L-lactide-co-glycolide); and a functional PEG-based star polymer, NCO-sP(EO-stat-PO). This topic was described in three major parts: the first part was materials based, concerning the chemical design and characterisation of the polymer scaffolds; the focus was then shifted to the cellular response to this fibrous scaffold; and finally the in vivo performance of the material was preliminarily assessed. The first steps towards an electrospun mesh started with adjusting the spinning parameters for the generation of homogeneous fibres. As reported in Chapter 3 a suitable setup configuration was on the one hand comprised of a spinning solution that consisted of 28.5 w/v\% PLGA RG 504 and 6 w/v\% NCO-sP(EO-stat-PO) in 450 µL acetone, 50 µL DMSO and 10 µL of an aqueous trifluoroacetic acid solution. On the other hand an ideal spinning behaviour was achieved at process parameters such as a flow rate of 0.5 mL/h, spinneret to collector distance of 12-16 cm and a voltage of 13 kV. The NCO-sP(EO-stat-PO) containing fibres proved to be highly hydrophilic as the functional additive was present on the fibre surface. Furthermore, the fibres featured a bulk degradation pattern as a consequence of the proportion of PLGA. Besides the morphologic similarity to ECM fibres, the functionality of the electrospun fibres is also decisive for a successful ECM mimicry. In Chapter 4, the passive as well as active functionality of the fibres was investigated. The fibres were required to be protein repellent to prevent an unspecific cell adhesion. This was proven as even 6.5 \% sP(EO-stat-PO) in the PLGA fibres reduced any unspecific protein adsorption of bovine serum albumin and foetal calf serum to less than 1 \%. However, avidin based proteins attached to the fibres. This adhesion process was avoided by an additional fibre surface treatment with glycidol. The active functionalisation of NCO-sP(EO-stat-PO)/PLGA fibres was investigated with two fluorescent dyes and biocytin. A threefold, chemically orthogonal, fibre modification was achieved with these dyes. The chapters about the chemical and mechanical properties laid the basis for the in vitro chapters where a specific fibre functionalisation with peptides was conducted to analyse the cell adhesion and biochemical expressions. Beginning with fibroblasts in Chapter 5 the focus was on the specific cell adhesion on the electrospun fibres. While NCO-sP(EO-stat-PO)/PLGA fibres without peptides did not allow any adhesion of fibroblasts, a fibre modification with GRGDS (an adhesion mediating peptide sequence) induced the adhesion and spreading of human dermal fibroblasts on the fibrous scaffolds. The control sequence GRGES that has no adhesion mediating qualities did not lead to any cell adhesion as observed on fibres without modifications. While the experiments of Chapter 5 were a proof-of-concept, in Chapter 6 a possible application in cartilage tissue engineering was examined. Therefore, primary human chondrocytes were seeded on fibrous scaffolds with various peptide sequences. Though the chondrocytes exhibited high viability on all scaffolds, an active interaction of cells and fibres was only found for the decorin derived sequence CGKLER. Live-cell-imaging revealed both cell attachment and migration within CGKLER-modified meshes. As chondrocytes undergo a de-differentiation towards a fibroblast-like phenotype, the chondrogenic re-differentiation on these scaffolds was investigated in a long term cell culture experiment of 28 days. Therefore, the glycosaminoglycan production was analysed as well as the mRNA expression of genes coding for collagen I and II, aggrecan and proteoglycan 4. In general only low amounts of the chondrogenic markers were measured, suggesting no chondrogenic differentiation. For conclusive evidence follow-up experiments are required that support or reject the findings. The success of an implant for tissue engineering relies not only on the response of the targeted cell type but also on the immune reaction caused by leukocytes. Hence, Chapter 7 dealt with primary human macrophages and their behaviour and phenotype on two-dimensional (2D) surfaces compared to three-dimensional (3D) fibrous substrates. It was found that the general non-adhesiveness of NCO-sP(EO-stat-PO) surfaces and fibres does not apply to macrophages. The cells aligned along the fibres on surfaces or resided in the pores of the meshes. On flat surfaces without 3D structure the macrophages showed a retarded adhesion kinetic accompanied with a high migratory activity indicating their search for a topographical feature to adhere to. Moreover, a detailed investigation of cell surface markers and chemokine signalling revealed that macrophages on 2D surfaces exhibited surface markers indicating a healing phenotype while the chemokine release suggested a pro-inflammatory phenotype. Interestingly, the opposite situation was found on 3D fibrous substrates with pro-inflammatory surface markers and pro-angiogenic cytokine release. As the immune response largely depends on cellular communication, it was concluded that the NCO-sP(EO-stat-PO)/PLGA fibres induce an adequate immune response with promising prospects to be used in a scaffold for tissue engineering. The final chapter of this thesis reports on a first in vivo study conducted with the presented electrospun fibres. Here, the fibres were combined with a polypropylene mesh for the treatment of diaphragmatic hernias in a rabbit model. Two scaffold series were described that differed in the overall surface morphology: while the fibres of Series A were incorporated into a thick gel of NCO-sP(EO-stat-PO), the scaffolds of Series B featured only a thin hydrogel layer so that the overall fibrous structure could be retained. After four months in vivo the treated defects of the diaphragm were significantly smaller and filled mainly with scar tissue. Thick granulomas occurred on scaffolds of Series A while the implants of Series B did not induce any granuloma formation. As a consequence of the generally positive outcome of this study, the constructs were enhanced with a drug release system in a follow-up project. The incorporated drug was the MMP-inhibitor Ilomastat which is intended to reduce the formation of scar tissue. In conclusion, the simple and straight forward fabrication, the threefold functionalisation possibility and general versatile applicability makes the meshes of NCO-sP(EO-stat-PO)/PLGA fibres a promising candidate to be applied in tissue engineering scaffolds in the future.},
  subject      = {Nanofaser},
  language  = {en}
}
@phdthesis{Waag2013,
  author    = {Waag, Thilo},
  title     = {Funktionalisierung von Nanodiamanten f{\"u}r Wirkstofftransport und Knochenersatzmaterialien},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-94597},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2013},
  abstract  = {Ziel der vorliegenden Arbeit ist das Design, die Synthese und das anschließende Testen von Nanodiamant-Wirkstoff-Konjugaten. Daf{\"u}r m{\"u}ssen zun{\"a}chst Nanodiamanten mit geeigneten Linkersystemen funktionalisiert werden, um anschließend verschiedene pharmazeutische Wirkstoffe auf der Diamantoberfl{\"a}che zu immobilisieren. Die Wirksamkeit der so angebundenen Inhibitoren auf die verschiedenen Erreger muss anschließend in vitro und in vivo getestet werden. Auch die Art der Aufnahme der Nanodiamanten in die verschiedenen Zellen muss untersucht werden. Dazu sollen Fluoreszenzfarbstoffe, wie z.B. Oregon Green 488, auf der Diamantoberfl{\"a}che immobilisiert werden.},
  subject      = {Diamant},
  language  = {de}
}
@phdthesis{Balk2015,
  author    = {Balk, Anja},
  title     = {Ionic liquids of active pharmaceutical ingredients: A novel platform addressing solubility challenges of poorly water soluble drugs},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-121925},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Starting in the late 1990s ionic liquids (ILs) gained momentum both in academia as well as industry. ILs are defined as organic salts with a melting point below 100 °C. Active pharmaceutical ingredients (APIs) may be transferred into ILs by creating salts with a bulky counterion with a soft electron density. ILs have demonstrated the potential to tune important pharmaceutical features such as the solubility and the dissolution rate, particularly addressing the challenge of poor water soluble drugs (PWSD). Due to the tunability of ILs, modification of physico-chemical properties of APIs may be envisioned without any modifications of the chemical structure. In the first chapter the potential as well as the limitation of ILs are discussed. The chapter commences with an overview of preparation and characterization of API-ILs. Moreover, examples for pharmaceutical parameters are presented which may be affected by IL formation, including the dissolution rate, kinetic solubility or hygroscopicity as well as biopharmaceutical performance and toxicology. The impact of IL formation on those pharmaceutically relevant features is highlighted, resulting in a blueprint for a novel formulation concept to overcome PWSD challenges without the need for structural changes of the API. Within the second chapter the IL concept is detailed for one specific API - counterion combination. A poorly water soluble acidic API against migraine attacks was transformed into an IL in an effort to minimize the time to maximum plasma concentration (tmax) and optimize the overall bioavailability. These studies were conducted in parallel to a prodrug of the API for comparison of the IL strategy versus a strategy involving modification of the API's structure. A significantly longer duration of API supersaturation and a 700 fold faster dissolution rate of the IL in comparison to the free acid were obtained and the underlying mechanism was elucidated. The transepithelial absorption was determined using Caco-2 cell layers. For the IL about 3 times more substance was transported in comparison to the prodrug when substances were applied as suspensions, despite the higher permeability of the prodrug, as increased solubility of the IL exceeded this effect. Cytotoxicity of the counterion was assessed in hepatic, renal and macrophage cell lines, respectively, and IC50 values were in the upper µM / lower mM range. The outcome of the study suggested the IL approach instrumental for tuning biopharmaceutical properties, without structural changes of the API as required for preparation of prodrugs. Thus the toolbox for formulation strategies of poorly water soluble drugs could be extended by an efficient concept. The third chapter focuses on the effect of different counterions on the physico-chemical properties of an API-IL, in particular to overcome the challenge of poor water solubility. Therefore, the same poorly water soluble acidic API against migraine attacks mentioned above was combined with 36 counterions resulting in ILs and low lattice enthalpy salts (LLES). Depending on the counterions, different dissolution rates, durations of supersaturation and hygroscopicities were obtained and release profiles could be tailored from immediate to sustained release. Besides, in vitro the cytotoxicity of the counterions was assessed in three cell lines. Using molecular descriptors such as the number of hydrophobic atoms, the graph theoretical diameter and the number of positive charges of the counterion, the dissolution rate, supersaturation and hygroscopicity as well as the cytotoxicity of counterions could be adequately modeled, rendering it possible to predict properties of new LLESs. Within the forth chapter different poorly water soluble APIs were combined with the counterion tetrabutylphosphonium (TBP) studying the impact on the pharmaceutical and physical properties of the APIs. TBP-ILs and low lattice enthalpy salts were prepared of the acidic APIs Diclofenac, Ibuprofen, Ketoprofen, Naproxen, Sulfadiazine, Sulfamethoxazole and Tolbutamide. NMR and IR spectroscopy, DSC, XRPD, DVS and dissolution rate measurements, release profiles and saturation concentration measurements were used to characterize the free acids and TBP salts as compared to the corresponding sodium salts. The TBP salts as compared to the free acids displayed lower melting points and glass transition temperatures and up to 1000 times higher dissolution rates. The increase in the dissolution rate directly correlated with the salts' hygroscopicity, an aspect which is critically discussed in terms of pharmaceutical translation challenges. In summary TBP ILs of solid salts were proved instrumental to approach the challenge of poor water solubility. The outcome profiled tailor-made counterions as a powerful formulation strategy to address poor water solubility, hence bioavailability and ultimately therapeutic potential of challenging APIs. In summary, a plethora of ILs and LLESs were prepared by combination of different acidic APIs and counterions. The IL and LLESs concept was compared to conventional salt and prodrug strategies. By choice of the counterion, biopharmaceutical relevant parameters were deliberately modified and release profiles were tuned ranging from immediate to prolonged release. The impact of distinct structural counterion features controlling the dissolution, supersaturation, hygroscopicity and counterion cytotoxicity were identified, correlations were presented and predictive models were built. ILs and LLESs could be proven to be a powerful concept for the formulation of poorly water soluble acidic APIs.},
  subject      = {Arzneimittel},
  language  = {en}
}
@phdthesis{Wagenhoefer2014,
  author    = {Wagenh{\"o}fer, Julian},
  title     = {Mikro- und mesopor{\"o}se Silicate als Wirkstoffspeichersysteme},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-103848},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2014},
  abstract  = {Mesopor{\"o}se Silica-Materialien (MSM) und mikropor{\"o}se Zeolithe besitzen große innere Oberfl{\"a}chen und eine damit verbundene hohe Speicherkapazit{\"a}t von verschiedenen Molek{\"u}len. Auf Grund dieser Eigenschaften stehen por{\"o}se, silicatische Materialien seit etwa 10 Jahren im Focus der Entwicklung neuartiger Wirkstoffspeichersysteme (WSS). Die innerhalb dieser Thematik ver{\"o}ffentlichten wissenschaftlichen Arbeiten konnten die Fragestellungen nach dem exakten Mechanismus der Wirkstoffspeicherung und Wiederfreisetzung bisher nicht komplett beantworten. Die vorliegende Arbeit besch{\"a}ftigt sich im Besonderen mit der Beladung und Abgabe des Lokalan{\"a}sthetikum Lidocain-Hydrochlorid (LidHCl) in bekannten MSM wie SBA15, MCM41 oder HMS, sowie in unterschiedlich modifizierten Zeolithen vom Typ FAU und BEA. Zus{\"a}tzlich wurde der Einfluss von organischen Ankergruppen innerhalb der Porenstruktur von SBA15 auf dessen Sorptions-eigenschaften hin untersucht. Ziel der Promotionsarbeit ist die Aufkl{\"a}rung des Speicher- und Freisetzungs-mechanismus dieses speziellen Speichersystems. Dazu wurden zun{\"a}chst detaillierte Analysen der reinen und der mit Wirkstoff beladenen Matrizes via N2-Sorption (BET-, BJH-, t-plot-Methode), XRD, SAXS, DSC und TG durchgef{\"u}hrt. Außerdem wurden grafische Profile erstellt, die das Verh{\"a}ltnis der ad- bzw. desorbierten Wirkstoffmengen gegen die bei der Beladung eingesetzten Wirkstoffkonzentrationen (Speicherprofil) bzw. gegen die bei der Wiederfreisetzung verstrichene Zeit (Freisetzungsprofil) wiedergeben. Durch die Kombination dieser Untersuchungsmethoden konnte der jeweilige Sorptionsmechanismus, sowie der Speicherort der Wirkstoffmolek{\"u}le innerhalb der ausgew{\"a}hlten Matrix erfasst werden. Der Vergleich der verschiedenen, hier untersuchten Speichersysteme zeigt, dass neben der Porengr{\"o}ße, die Art der Adsorbens-Adsorbat-Wechselwirkung, aber auch die Stabilit{\"a}t der Porenstruktur einen großen Einfluss auf die Sorption von Molek{\"u}len nimmt.},
  subject      = {Silicate},
  language  = {de}
}
@phdthesis{Werner2015,
  author    = {Werner, Vera},
  title     = {Pharmaceutically relevant protein-protein interactions for controlled drug delivery},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-117409},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Protein-protein interactions play a crucial role in the development of drug delivery devices for the increasingly important biologicals, including antibodies, growth factors and cytokines. The understanding thereof might offer opportunities for tailoring carriers or drug proteins specifically for this purpose and thereby allow controlled delivery to a chosen target. The possible applications range from trigger-dependent release to sustained drug delivery and possibly permanently present stimuli, depending on the anticipated mechanism. Silk fibroin (SF) is a biomaterial that is suitable as a carrier for protein drug delivery devices. It combines processability under mild conditions, good biocompatibility and stabilizing effects on incorporated proteins. As SF is naturally produced by spiders and silkworms, the understanding of this process and its major factors might offer a blueprint for formulation scientists, interested in working with this biopolymer. The natural process of silk spinning covers a fascinating versatility of aggregate states, ranging from colloidal solutions through hydrogels to solid systems. The transition among these states is controlled by a carefully orchestrated process in vivo. Major players within the natural process include the control of spatial pH throughout passage of the silk dope, the composition and type of ions, and fluid flow mechanics within the duct, respectively. The function of these input parameters on the spinning process is reviewed before detailing their impact on the design and manufacture of silk based drug delivery systems (DDS). Examples are reported including the control of hydrogel formation during storage or significant parameters controlling precipitation in the presence of appropriate salts, respectively. The review details the use of silk fibroin to develop liquid, semiliquid or solid DDS with a focus on the control of SF crystallization, particle formation, and drug-SF interaction for tailored drug load. Although we were able to show many examples for SF drug delivery applications and there are many publications about the loading of biologics to SF systems, the mechanism of interaction between both in solution was not yet extensively explored. This is why we made this the subject of our work, as it might allow for direct influence on pharmaceutical parameters, like aggregation and drug load. In order to understand the underlying mechanism for the interaction between SF and positively charged model proteins, we used isothermal titration calorimetry for thermodynamic characterization. This was supported by hydrophobicity analysis and by colloidal characterization methods including static light scattering, nanoparticle tracking analysis and zeta potential measurements. We studied the effects of three Hofmeister salts - NaCl (neutral), NaSCN (chaotropic) and Na2SO4 (cosmotropic) - and the pH on the interaction of SF with the model proteins in dependence of the ratio from one to another. The salts impacted the SF structure by stabilizing (cosmotropic) or destabilizing (chaotropic) the SF micelles, resulting in completely abolished (cosmotropic) or strongly enhanced (chaotropic) interaction. These effects were responsible for different levels of loading and coacervation when varying type of salt and its concentration. Additionally, NaCl and NaSCN were able to prolong the stability of aqueous SF solution during storage at 25°C in a preliminary study. Another approach to influence protein-protein interactions was followed by covalent modification. Interleukin-4 (IL-4) is a cytokine driving macrophages to M2 macrophages, which are known to provide anti-inflammatory effects. The possibility to regulate the polarization of macrophages to this state might be attractive for a variety of diseases, like atherosclerosis, in which macrophages are involved. As these cases demand a long-term treatment, this polarization was supposed to be maintained over time and we were planning to achieve this by keeping IL-4 permanently present in an immobilized way. In order to immobilize it, we genetically introduced an alkyne-carrying, artificial amino acid in the IL-4 sequence. This allowed access to a site-specific click reaction (Cu(I)-catalyzed Huisgen azide-alkyne cycloaddition) with an azide partner. This study was able to set the basis for the project by successful expression and purification of the IL-4 analogue and by proving the availability for the click reaction and maintained bioactivity. The other side of this project was the isolation of human monocytes and the polarization and characterization of human macrophages. The challenge here was that the majority of related research was based on murine macrophages which was not applicable to human cells and the successful work was so far limited to establishing the necessary methods. In conclusion, we were able to show two different methods that allow the influence of protein-protein interactions and thereby the possible tailoring of drug loading. Although the results were very promising for both systems, their applicability in the development of drug delivery devices needs to be shown by further studies.},
  subject      = {Protein-Protein-Wechselwirkung},
  language  = {en}
}